As of close of business last night, China Pharma Holdings Inc.’s stock clocked out at $0.08, down -7.41% from its previous closing price of $0.08. In other words, the price has decreased by -$0.0060 from its previous closing price. On the day, 974388 shares were traded.
Ratios:
To gain a deeper understanding of CPHI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.82. In the meantime, Its Debt-to-Equity ratio is 0.88 whereas as Long-Term Debt/Eq ratio is at 0.24.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on January 08, 2010, initiated with a Mkt Outperform rating and assigned the stock a target price of $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CPHI now has a Market Capitalization of 4.30M and an Enterprise Value of 8.32M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55 while its Price-to-Book (P/B) ratio in mrq is 0.35. Its current Enterprise Value per Revenue stands at 1.07 whereas that against EBITDA is -244.61.
Stock Price History:
Over the past 52 weeks, CPHI has reached a high of $0.75, while it has fallen to a 52-week low of $0.07. The 50-Day Moving Average of the stock is 0.0968, while the 200-Day Moving Average is calculated to be 0.1804.
Shares Statistics:
It appears that CPHI traded 1.90M shares on average per day over the past three months and 2.32M shares per day over the past ten days. A total of 56.98M shares are outstanding, with a floating share count of 21.46M. Insiders hold about 62.34% of the company’s shares, while institutions hold 1.07% stake in the company. Shares short for CPHI as of Feb 15, 2024 were 467.99k with a Short Ratio of 0.25, compared to 50.58k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.88% and a Short% of Float of 1.22%.
Earnings Estimates
As of right now, 0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $1.5. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
